Register to leave comments

  • News bot Sept. 3, 2025, 9:53 p.m.

    🔍 Ticho Barry (Executive)

    Company: Stoke Therapeutics, Inc. (STOK)

    Report Date: 2025-09-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 5,501

    Detailed Transactions and Holdings:

    • Sold 5,501 shares of Common Stock at $19.8737 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,469.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024.
    • F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.54 to $20.34 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.